|
|
||||||||
Regular Article |
Received August 10, 2004; revised March 21, May 12, 2005; accepted May 31, 2005. From the Univ. of Pittsburgh, Pittsburgh, PA; INSERM, Paris, France; and the Univ. of Perugia, Perugia, Italy Send correspondence and reprint requests to Judith Saxton, Ph.D., Dept. of Neurology, Kaufman Medical Building, Suite 802, 3471 Fifth Ave., Pittsburgh, PA 15213. e-mail: Saxtonja{at}upmc.edu
© 2005 American Association for Geriatric Psychiatry
Objective: The authors sought to develop a short form of the Severe Impairment Battery (SIB). Methods: Authors describe the development of an empirically-derived short form of the SIB (SIBS) by use of data from 191 subjects with severe dementia in the United States and France. Results: Mean (standard deviation) Mini-Mental State Exam scores for the American and French samples were 7.7 (4.8) and 5.7 (3.4), respectively, and original SIB scores were 71.87 (18.34) and 58.38 (26.86), respectively. Exploratory factor analyses were conducted separately and in combination for the two samples, to determine the number of clinically meaningful factors. An eight-factor model, explaining 60.2% of the common variance, was selected. The eight constructs were described as: expressive language, memory (verbal and nonverbal), social interaction, color-naming, praxis, reading and writing, fluency, and attention. Derived SIBS scores were 38.41 (9.12) and 29.79 (13.17) for the American and French samples, respectively. Conclusions: The original SIB is a valid and reliable research tool developed to enable reliable assessment of patients with severe dementia; it takes approximately 30 minutes to administer. The SIBS takes only 1015 minutes to administer, making it more appropriate for use in patients with very severe dementia, while it maintains the attributes of the original SIB.
Key Words: Dementia Test Batteries Severe Impairment Battery
This article has been cited by other articles:
![]() |
P. Raina, P. Santaguida, A. Ismaila, C. Patterson, D. Cowan, M. Levine, L. Booker, and M. Oremus Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline Ann Intern Med, March 4, 2008; 148(5): 379 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yaffe Research and Care of Patients With Dementia: Moving Beyond Memory Loss Am J Geriatr Psychiatry, November 1, 2005; 13(11): 921 - 925. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ALL ISSUES | SEARCH | TABLE OF CONTENTS |